13F HOLDINGS REPORT
Omega Fund Management, LLC
Quarter ended Q1 2023 · Filed February 13, 2023 · Accession 0000950123-23-002007
Total Value
$296.7M
Positions
16
Other Managers
0
Confidential Omitted
No
Holdings (16)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Imago Biosciences | 45250K107 | 3,018,737 | $108.5M | 36.57% |
| 2 | Replimune Group | REPL | 3,361,806 | $91.4M | 30.82% |
| 3 | Nuvation Bio | NUVB | 15,072,340 | $28.9M | 9.75% |
| 4 | Morphic Holding | 61775R105 | 597,723 | $16.0M | 5.39% |
| 5 | Alpine Immune Sciences | 02083G100 | 2,029,580 | $14.9M | 5.03% |
| 6 | Cincor | 17240Y109 | 560,985 | $7.9M | 2.65% |
| 7 | Kronos Bio | 50107A104 | 3,818,283 | $6.2M | 2.08% |
| 8 | Ikena Oncology | 45175G108 | 2,249,123 | $6.0M | 2.02% |
| 9 | Paratek Pharmaceuticals | 699374302 | 1,971,241 | $3.7M | 1.24% |
| 10 | Theseus Pharmaceuticals | 88369M101 | 711,479 | $3.5M | 1.19% |
| 11 | Sana Biotechnology, Inc. | SANA | 843,750 | $3.3M | 1.12% |
| 12 | Immunic Inc | IMUX | 1,788,160 | $2.5M | 0.84% |
| 13 | Spruce Biosciences | SPRB | 2,161,022 | $2.3M | 0.79% |
| 14 | Syros Pharmaceuticals | 87184Q206 | 251,270 | $902,059 | 0.30% |
| 15 | Jounce Therapeutics | 481116101 | 275,513 | $305,819 | 0.10% |
| 16 | Senti Biosciences, Inc. | SNTI | 195,792 | $276,067 | 0.09% |